The Science Behind Leech Therapy
FDA clearance, peer-reviewed research, and clinical evidence from major U.S. academic medical centers
Structured evidence catalogue: 137 RCTs (GRADE-rated, PMID-verified), 199 conditions (Tier A/B/C classified), and faceted search across all five registries.
Last updated: November 1, 2026
Leech therapy is not alternative medicine. It is an evidence-based integrative therapy, delivered with FDA-cleared 510(k) medicinal leeches, used at major U.S. academic medical centers, with published case reports from teams including Johns Hopkins and Massachusetts General Hospital surgeons. The science behind it is published in peer-reviewed medical journals and supported by clinical trials.
This page summarizes the key evidence so you can make informed decisions about your care.
FDA Regulatory Status
FDA-Cleared Indication
FDA-Cleared Medical Device. Medicinal leeches received 510(k) clearance (K040187) in June 2004 as FDA 510(k)-cleared medical devices for relief of venous congestion following surgical procedures.
Device Classification
510(k)-Cleared Medical Device Product Code: NRN Regulatory pathway: 510(k) Device class: Unclassified (pre-amendments device; no classification regulation number) Quality system regulation: 21 CFR Part 820 (QMSR)
FDA-Cleared Indication
Relief of venous congestion in tissue flaps and grafts following microsurgical procedures where venous insufficiency is present.
Key FDA Milestones
- • 2004: First 510(k) clearance (K040187, Ricarimpex)
- • 2014: Second clearance (K132958, Biopharm)
- • 2015: Third clearance (K140907, Carolina Biological Supply Co.)
- • 2024: Regulatory transfer to CBER
What FDA Clearance Means
Evidence by Condition
Clinical evidence for hirudotherapy varies by condition. Here’s a summary of the current research field, organized by strength of evidence.
Strong Clinical Evidence
Venous Congestion in Reconstructive Surgery
This is the FDA-cleared indication and the most well-established use of medicinal leeches in American medicine. Leeches are used to relieve blood pooling in tissue flaps after microsurgery.
Key Finding
Leech therapy is widely used to salvage congested flaps in reconstructive surgery, although no randomized controlled trials exist. Published case series and systematic reviews report flap salvage rates of 65–85% when leeches are used for venous congestion.
Published Evidence
- • Whitaker et al. (2012). Microsurgery. Systematic review of 277 cases.
- • Herlin et al. (2017). Annales de Chirurgie Plastique Esthétique. Systematic review of flap salvage outcomes.
- • Nguyen et al. (2012). Microsurgery. Flap salvage outcomes in 39 patients.
Knee Osteoarthritis
Multiple randomized controlled trials (RCTs) — the gold standard in medical research — show leech therapy provides significant pain relief and improved function in knee osteoarthritis.
Key Finding
A landmark RCT published in the Annals of Internal Medicine (2003) found that a single application of 4–6 leeches provided significantly greater pain reduction at day 7 than topical diclofenac, with function, stiffness, and total-symptom scores remaining significantly better through the 3-month (day 91) follow-up (a common anti-inflammatory gel).
Published Evidence
- • Michalsen et al. (2003). Annals of Internal Medicine. RCT, n=51. Leech therapy vs. topical diclofenac.
- • Andereya et al. (2008). Acta Orthopaedica. Randomized, patient-blinded, sham-controlled trial (n=113), knee OA.
- • Lauche et al. (2014). Clin J Pain. Meta-analysis (3 RCTs + 1 CCT, 237 patients). Leech therapy for thumb carpometacarpal osteoarthritis.
Growing Clinical Evidence
Chronic Venous Insufficiency
A small uncontrolled prospective series of 20 patients with complicated varicose veins reported healing of all varicose ulcers, decreased edema and limb girth in 95% of patients and decreased hyperpigmentation in 75%; the authors call for controlled trials.
Bapat et al. (1998), Indian Journal of Medical Research
Hypertension
Blood-pressure reduction after leech therapy has been described only in uncontrolled Russian-language reports that are not independently verifiable.
No controlled clinical trial
Pain Syndromes
Clinical observations and pilot studies report significant pain relief for chronic pain conditions. The analgesic compounds in leech SGS provide a unique multi-targeted approach to pain management.
Bäcker et al. (2011), Clinical Journal of Pain
Wound Healing
Leech-derived compounds show promising wound-healing properties. The combination of improved circulation, anti-inflammatory effects, and antimicrobial peptides creates favorable conditions for tissue repair.
Preclinical and mechanistic evidence; no controlled clinical trial
Emerging Research
Dermatological Applications
Early studies explore leech therapy for psoriasis, eczema, and other skin conditions. The anti-inflammatory compounds show particular promise.
Drug Development
NIH-funded research explores leech-derived compounds for new medications. Hirudin analogs are already used as prescription anticoagulants (bivalirudin, desirudin).
Post-Thrombotic Syndrome
No study of leech therapy for post-thrombotic syndrome has been published; interest rests on the anticoagulant and anti-inflammatory properties of leech SGS.
How the Science Works
The therapeutic effect of leech therapy comes from more than 100 bioactive substances in leech SGS. These natural molecules work together to produce multiple beneficial effects simultaneously — something no single medication can replicate.
Anticoagulation
Hirudin prevents blood clotting, improving circulation to compromised tissue
Anti-Inflammation
Bdellins and eglins reduce swelling and inflammatory response
Pain Relief
Salivary components with local effects on sensation provide pain reduction at the bite site.
Vasodilation
Histamine-like compounds widen blood vessels, enhancing blood flow to treatment area
The Multi-Compound Advantage
Use in American Hospitals
Leech therapy is an established treatment at major U.S. medical centers. It is most commonly used in plastic and reconstructive surgery departments for post-operative care.
Hospitals Using Leech Therapy
This is a representative list. Leech therapy is available at many medical facilities across the United States, primarily in surgical and reconstructive settings.
Ongoing Research
The study of leech-derived compounds is an active area of biomedical research. Here are some key directions:
Drug Development from Leech Compounds
Leech-derived molecules have already produced FDA-approved medications:
- • Bivalirudin (Angiomax®) — used during heart procedures. Based on hirudin.
- • Desirudin (Iprivask®) — prevents blood clots after hip replacement. Recombinant hirudin; FDA-approved in 2003 and since discontinued in the US.
Genomic & Proteomic Studies
Advanced molecular techniques are identifying new bioactive compounds in leech SGS. Researchers at the NIH, University of Wisconsin, and other institutions are mapping the complete salivary proteome, revealing molecules that may lead to future treatments for cardiovascular disease, chronic pain, and autoimmune conditions.
Evidence-Based Integrative Medicine
Key Publications
Below are selected peer-reviewed publications that form the evidence base for hirudotherapy. All are indexed in PubMed (National Library of Medicine).
Michalsen A, Klotz S, Lüdtke R, Moebus S, Spahn G, Dobos GJ (2003)
“Effectiveness of leech therapy in osteoarthritis of the knee: a randomized, controlled trial”
Annals of Internal Medicine, 139(9):724-30. PubMed: 14597456
Landmark RCT. Leech therapy reduced knee OA pain more than topical diclofenac at day 7 (primary endpoint); function and stiffness benefits lasted to day 91.
Whitaker IS, Cheung CK, Chahal CA, Karoo RO, Gulati A, Foo IT (2005)
“By what mechanism do leeches help to salvage ischaemic tissues? A review”
British Journal of Oral and Maxillofacial Surgery, 43(2):155-60. PubMed: 15749217
Review of the anatomy, physiology and pharmacological mechanisms of action of leeches.
Herlin C, Bertheuil N, Bekara F, Boissiere F, Sinna R, Chaput B (2017)
“Leech therapy in flap salvage: systematic review and practical recommendations”
Annales de Chirurgie Plastique Esthétique, 78(2):e84-e90. PubMed: 27427444
Comprehensive systematic review of flap salvage outcomes.
Sig AK, Guney M, Uskudar Guclu A, Ozmen E (2017)
“Medicinal leech therapy — an overall perspective”
Integrative Medicine Research, 6(4):337-343. PubMed: 29296560
Detailed overview of bioactive compounds and clinical applications.
Lauche R, Cramer H, Langhorst J, Dobos G (2014)
“A systematic review and meta-analysis of medical leech therapy for osteoarthritis of the knee”
Clinical Journal of Pain, 30(1):63-72. PubMed: 23446069
Meta-analysis confirming clinically meaningful pain reduction.
For a complete list of clinical evidence by condition, visit our Clinical Evidence pages.
Explore the Science
Clinical Evidence Hub
Detailed evidence pages for each condition, with study summaries and outcomes data.
Salivary Complex
The 100+ bioactive compounds in leech SGS and their mechanisms of action.
Hirudin
The most studied leech-derived anticoagulant and its role in modern medicine.
Drug Development
How leech compounds are being developed into new pharmaceutical treatments.
Patient Guide
Practical guide to what happens before, during, and after leech therapy.
FDA Regulatory Status
Complete regulatory history of medicinal leeches as FDA 510(k)-cleared medical devices.